Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.

Chang E, Apolo AB, Bangs R, Chisolm S, Duddalwar V, Efstathiou JA, Goldberg KB, Hansel DE, Kamat AM, Kluetz PG, Lerner SP, Plimack E, Prowell T, Singh H, Suzman D, Yu EY, Zhang H, Beaver JA, Pazdur R, Weinstock C, Galsky MD

Open source

DOI: 10.1038/s41585-021-00505-w
Published: 2022 Jan
Container: Nature reviews. Urology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41585-021-00505-w,
  title = {Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.},
  author = {Chang E and Apolo AB and Bangs R and Chisolm S and Duddalwar V and Efstathiou JA and Goldberg KB and Hansel DE and Kamat AM and Kluetz PG and Lerner SP and Plimack E and Prowell T and Singh H and Suzman D and Yu EY and Zhang H and Beaver JA and Pazdur R and Weinstock C and Galsky MD},
  year = {2022},
  journal = {Nature reviews. Urology},
  doi = {10.1038/s41585-021-00505-w},
  url = {https://doi.org/10.1038/s41585-021-00505-w}
}

RIS

TY  - JOUR
TI  - Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.
AU  - Chang E
AU  - Apolo AB
AU  - Bangs R
AU  - Chisolm S
AU  - Duddalwar V
AU  - Efstathiou JA
AU  - Goldberg KB
AU  - Hansel DE
AU  - Kamat AM
AU  - Kluetz PG
AU  - Lerner SP
AU  - Plimack E
AU  - Prowell T
AU  - Singh H
AU  - Suzman D
AU  - Yu EY
AU  - Zhang H
AU  - Beaver JA
AU  - Pazdur R
AU  - Weinstock C
AU  - Galsky MD
PY  - 2022
JO  - Nature reviews. Urology
DO  - 10.1038/s41585-021-00505-w
UR  - https://doi.org/10.1038/s41585-021-00505-w
ER  -

APA

E, C., AB, A., R, B., S, C., V, D., JA, E., KB, G., DE, H., AM, K., PG, K., SP, L., E, P., T, P., H, S., D, S., EY, Y., H, Z., JA, B., R, P., C, W., & MD, G. (2022). Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.. Nature reviews. Urology. https://doi.org/10.1038/s41585-021-00505-w

Source records

pubmed · retrieved 2026-09-26T06:28:49.589Z